3-year Postdoctoral Position in CRISPR-Based Genome Editing MDxCore, Department of Clinical Biochemistry, Rigshospitalet

Opportunity summary

3-year Postdoctoral Position in CRISPR-Based Genome Editing MDxCore, Department of Clinical Biochemistry, RigshospitaletApplications are invited for a full-time, 3-year postdoctoral position in CRISPR-based genome editing, with a preferred starting date of 1 October 2026. The Research Group The project will be conducted in the research group led by Chief Physician Maria Rossing at MDxCore, Rigshospitalet, and is funded by the Novo Nordisk Foundation. Our group consists of six dedicated researchers working within genomic medicine and translational research. We offer a collaborative research environment and excellent facilities in modern laboratories at Rigshospitalet. Project Details CRISPR-based genome editing offers the potential to correct disease-causing genetic variants at their source. Recent clinical successes demonstrate that precise, patient-specific genome editing is feasible, but such approaches remain exceptional and have not yet been translated into systematic therapeutic pipelines for rare disorders. This project aims to develop a patient-tailored CRISPR-based therapy for Glanzmann thrombasthenia, a severe inherited bleeding disorder caused by defects in platelet integrin αIIbβ31 …

This is a shortened extract from the public vacancy. Follow the original posting for the complete and authoritative description.